Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ragini Shyam"'
Autor:
Jennifer R. Chapman, Tyzoon K. Nomanbhoy, Matthew P. Patricelli, Hwan Geun Choi, Elena M. Cortizas, John Matthews, Nathanael S. Gray, Dita Gratzinger, Robert Tibshirani, Daxing Zhu, Ramiro E. Verdun, Ragini Shyam, Ranjana H. Advani, Jianming Zhang, Li Tan, Andrew J. Gentles, Yasodha Natkunam, Ezequiel Martinez, Xiaoyu Jiang, Sara J. Buhrlage, Izidore S. Lossos, Shruti Bhatt, Shideh Chinichian
Publikováno v:
Blood. 128(2)
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma, yet 40% to 50% of patients will eventually succumb to their disease, demonstrating a pressing need for novel therapeutic options. Gene expression profiling has
Autor:
Erik R. Zinser, James W. Murray, Anna E. Ritchie, Veronica P. Lance, Cecile Mioni, Ragini Shyam, Zackary I. Johnson
Publikováno v:
Journal of Marine Research. 68:283-308
Autor:
Pedro Farinha, Robert Tibshirani, Ranjana H. Advani, Ragini Shyam, Sandra J. Horning, Dita Gratzinger, Izidore S. Lossos, Javier Briones, Yasodha Natkunam, Shuchun Zhao, Neha Talreja, Laurie H. Sehn, Randy D. Gascoyne
Publikováno v:
BRITISH JOURNAL OF HAEMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
PubMed Central
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
PubMed Central
P>Diffuse large B cell lymphoma (DLBCL) is clinically and biologically heterogeneous. In most cases of DLBCL, lymphoma cells co-express vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2, suggesting autocrine in addition to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::325359ab7ba636c7e722b4e1d348c3f0
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12884
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12884
Autor:
Sara J. Buhrlage, Dita Gratzinger, Jennifer R. Chapman, Tyzoon K. Nomanbhoy, Li Tan, Nathanael S. Gray, Andrew J. Gentles, Ranjana H. Advani, Ezequiel Martinez, Jianming Zhang, Shideh Chinichian, Matthew P. Patricelli, Hwan Geun Choi, Daxing Zhu, Ragini Shyam, Shruti Bhatt, Yasodha Natkunam, John Matthews, Izidore S. Lossos, Xiaoyu Jiang
Publikováno v:
Blood. 122:643-643
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). The pathogenesis of DLBCL represents a multi-step process that involves the accumulation of multiple genetic and molecular lesions. Marked advances in the
Autor:
Charles D. Bangs, Yasodha Natkunam, Ash A. Alizadeh, Ronald Levy, Athena M. Cherry, Ranjana H. Advani, Holbrook E Kohrt, Matthew W. Anderson, Ragini Shyam
Publikováno v:
Blood. 116:3134-3134
Abstract 3134 Background: Concurrent t(14;18) and 8q24 translocations involving BCL2 and MYC in non-Hodgkin lymphomas (NHL) are rare, but are associated with a inferior overall survival (OS) regardless of the presenting or antecedent histological fea
Autor:
Izidore S. Lossos, Alvaro J. Alencar, Randy D. Gascoyne, Ranjana H. Advani, Robert Tibshirani, Ragini Shyam, Yaso Natkunam, Neha Talreja, Raquel Malumbres, Javier Briones
Publikováno v:
Blood. 114:624-624
Abstract 624 Background: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with a variable clinical outcome even in the current era of rituximab containing anthracycline-based chemotherapy (RCHOP). We have previously reported a 6 gene
Autor:
Izidore S. Lossos, Ash A. Alizadeh, Neha Talreja, Ronald Levy, Javier Briones, Roch Houot, Alvaro J. Alencar, Ranjana H. Advani, Andrew J. Gentles, Holbrook E Kohrt, Ragini Shyam, Yasodha Natkunam, Randy D. Gascoyne
Publikováno v:
Blood. 114:622-622
Abstract 622 Background: Several gene-expression signatures are predictive of prognosis in diffuse large-B-cell lymphoma (DLBCL), but the lack of practical methods for a genome-scale analysis has restricted their routine clinical applicability. Metho